Comparing Prevalence of Sarcopenia Using Twelve Sarcopenia Definitions in a Large Multinational European Population of Community-Dwelling Older Adults
Tóm tắt
Multinational prevalence data on sarcopenia among generally healthy older adults is limited. The aim of the study was to assess prevalence of sarcopenia in the DO-HEALTH European trial based on twelve current sarcopenia definitions. This is an analysis of the DO-HEALTH study including 1495 of 2157 community-dwelling participants age 70+ years from Germany, France, Portugal, and Switzerland with complete measurements of the sarcopenia toolbox including muscle mass by DXA, grip strength, and gait speed. The twelve sarcopenia definitions applied were Asian Working Group on Sarcopenia (AWGS1), AWGS2, Baumgartner, Delmonico, European Working Group on Sarcopenia in Older People (EWGSOP1), EWGSOP2, EWGSOP2-lower extremities, Foundation for the National Institutes of Health (FNIH1), FNIH2, International Working Group on Sarcopenia in Older People (IWGS), Morley, and Sarcopenia Definitions and Outcomes Consortium (SDOC). Mean age was 74.9 years (SD 4.4); 63.3% were women. Sarcopenia prevalence ranged between 0.7% using the EWGSOP2 or AWGS2 definition, up to 16.8% using the Delmonico definition. Overall, most sarcopenia definitions, including Delmonico (16.8%), Baumgartner (12.8%), FNIH1(10.5%), IWGS (3.6%), EWGSOP1 (3.4%), SDOC (2.0%), Morley (1.3%), and AWGS1 (1.1%) tended to be higher than the prevalence based on EWGSOP2 (0.7%). In contrast, the definitions AWGS2 (0.7%), EWGSOP2-LE (1.1%), FNIH2 (1.0%) — all based on muscle mass and muscle strength — showed similar lower prevalence as EWGSOP2 (0.7%). Moreover, most sarcopenia definitions did not overlap on identifying sarcopenia on an individual participant-level. In this multinational European trial of community-dwelling older adults we found major discordances of sarcopenia prevalence both on a population- and on a participant- level between various sarcopenia definitions. Our findings suggest that the concept of sarcopenia may need to be rethought to reliably and validly identify people with impaired muscle health.
Tài liệu tham khảo
Xu J, Wan CS, Ktoris K, et al. Sarcopenia Is Associated with Mortality in Adults: A Systematic Review and Meta-Analysis. Gerontology 2021:1–16. doi: https://doi.org/10.1159/000517099 [published Online First: 2021/07/28]
Beaudart C, Zaaria M, Pasleau F, et al. Health outcomes of sarcopenia: A systematic review and meta-analysis. PloS one 2017;12(1):e0169548. doi: https://doi.org/10.1371/journal.pone.0169548
Vellas B, Fielding RA, Bens C, et al. Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force. The Journal of frailty & aging 2018;7(1):2–9. doi: https://doi.org/10.14283/jfa.2017.30
Carvalho do Nascimento PR, Bilodeau M, Poitras S. How do we define and measure sarcopenia? A meta-analysis of observational studies. Age and ageing 2021;50(6):1906–13. doi: https://doi.org/10.1093/ageing/afab148 [published Online First: 2021/09/20]
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and ageing 2019;48(4):601. doi: https://doi.org/10.1093/ageing/afz046
Bhasin S, Travison TG, Manini TM, et al. Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium. Journal of the American Geriatrics Society 2020;68(7):1410–18. doi: https://doi.org/10.1111/jgs.16372
Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. The journals of gerontology Series A, Biological sciences and medical sciences 2014;69(5):547–58. doi: https://doi.org/10.1093/gerona/glu010
Alley DE, Shardell MD, Peters KW, et al. Grip strength cutpoints for the identification of clinically relevant weakness. The journals of gerontology Series A, Biological sciences and medical sciences 2014;69(5):559–66. doi: https://doi.org/10.1093/gerona/glu011
Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. Journal of the American Medical Directors Association 2011;12(4):249–56. doi: https://doi.org/10.1016/j.jamda.2011.01.003 [published Online First: 2011/04/30]
Bischoff-Ferrari HA, de Godoi Rezende Costa Molino C, Rival S, et al. DO-HEALTH: Vitamin D3 — Omega-3 — Home exercise — Healthy aging and longevity trial — Design of a multinational clinical trial on healthy aging among European seniors. Contemporary clinical trials 2021;100:106124. doi: https://doi.org/10.1016/j.cct.2020.106124
Stuck AK, Basile G, Freystätter G, et al. Predictive validity of current sarcopenia definitions (EWGSOP2, SDOC, and AWGS2) for clinical outcomes: A scoping review. Journal of cachexia, sarcopenia and muscle 2022;ahead of print.
Neumann S, Kwisda S, Krettek C, et al. Comparison of the Grip Strength Using the Martin-Vigorimeter and the JAMAR-Dynamometer: Establishment of Normal Values. In vivo 2017;31(5):917–24.
Van Ancum JM, Alcazar J, Meskers CGM, et al. Impact of using the updated EWGSOP2 definition in diagnosing sarcopenia: A clinical perspective. Archives of gerontology and geriatrics 2020;90:104125. doi: https://doi.org/10.1016/j.archger.2020.104125
Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age and ageing 2014;43(6):748–59. doi: https://doi.org/10.1093/ageing/afu115
Purcell SA, Mackenzie M, Barbosa-Silva TG, et al. Prevalence of Sarcopenic Obesity Using Different Definitions and the Relationship With Strength and Physical Performance in the Canadian Longitudinal Study of Aging. Front Physiol 2020;11:583825. doi: https://doi.org/10.3389/fphys.2020.583825 [published Online First: 20210121]
Daskalopoulou C, Stubbs B, Kralj C, et al. Physical activity and healthy ageing: A systematic review and meta-analysis of longitudinal cohort studies. Ageing Res Rev 2017;38:6–17. doi: https://doi.org/10.1016/j.arr.2017.06.003 [published Online First: 2017/06/27]
Bischoff-Ferrari HA, Orav JE, Kanis JA, et al. Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2015;26(12):2793–802. doi: https://doi.org/10.1007/s00198-015-3194-y
Scott D, Hayes A, Sanders KM, et al. Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adults. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2014;25(1):187–93. doi: https://doi.org/10.1007/s00198-013-2431-5 [published Online First: 2013/06/27]
Purcell SA, MacKenzie M, Barbosa-Silva TG, et al. Sarcopenia Prevalence Using Different Definitions in Older Community-Dwelling Canadians. J Nutr Health Aging 2020;24(7):783–90. doi: https://doi.org/10.1007/s12603-020-1427-z
Mayhew AJ, Amog K, Phillips S, et al. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age and ageing 2019;48(1):48–56. doi: https://doi.org/10.1093/ageing/afy106 [published Online First: 2018/07/28]
Sousa-Santos AR, Afonso C, Borges N, et al. Factors associated with sarcopenia and undernutrition in older adults. Nutr Diet 2019;76(5):604–12. doi: https://doi.org/10.1111/1747-0080.12542 [published Online First: 20190513]
Chew J, Yeo A, Yew S, et al. Muscle Strength Definitions Matter: Prevalence of Sarcopenia and Predictive Validity for Adverse Outcomes Using the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) Criteria. J Nutr Health Aging 2020;24(6):614–18. doi: https://doi.org/10.1007/s12603-020-1371-y
Jyvakorpi SK, Urtamo A, Kivimaki M, et al. Macronutrient composition and sarcopenia in the oldest-old men: The Helsinki Businessmen Study (HBS). Clin Nutr 2020;39(12):3839–41. doi: https://doi.org/10.1016/j.clnu.2020.04.024 [published Online First: 20200424]
Reiss J, Iglseder B, Alzner R, et al. Consequences of applying the new EWGSOP2 guideline instead of the former EWGSOP guideline for sarcopenia case finding in older patients. Age and ageing 2019;48(5):719–24. doi: https://doi.org/10.1093/ageing/afz035
Harvey NC, Orwoll E, Kwok T, et al. Sarcopenia Definitions as Predictors of Fracture Risk Independent of FRAX((R)), Falls, and BMD in the Osteoporotic Fractures in Men (MrOS) Study: A Meta-Analysis. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 2021;36(7):1235–44. doi: https://doi.org/10.1002/jbmr.4293 [published Online First: 2021/04/09]
Stuck AK, Mader NC, Bertschi D, et al. Performance of the EWGSOP2 Cut-Points of Low Grip Strength for Identifying Sarcopenia and Frailty Phenotype: A Cross-Sectional Study in Older Inpatients. International journal of environmental research and public health 2021;18(7) doi: https://doi.org/10.3390/ijerph18073498
Cawthon PM, Peters KE, Cummings SR, et al. Association Between Muscle Mass Determined by D3 -Creatine Dilution and Incident Fractures in a Prospective Cohort Study of Older Men. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 2022;37(7):1213–20. doi: https://doi.org/10.1002/jbmr.4505 [published Online First: 2022/03/08]
Riuzzi F, Sorci G, Arcuri C, et al. Cellular and molecular mechanisms of sarcopenia: the S100B perspective. Journal of cachexia, sarcopenia and muscle 2018;9(7):1255–68. doi: https://doi.org/10.1002/jcsm.12363 [published Online First: 2018/12/01]
Perkisas S, Bastijns S, Baudry S, et al. Application of ultrasound for muscle assessment in sarcopenia: 2020 SARCUS update. European geriatric medicine 2021;12(1):45–59. doi: https://doi.org/10.1007/s41999-020-00433-9 [published Online First: 2021/01/03]
Tagliafico AS, Bignotti B, Torri L, et al. Sarcopenia: how to measure, when and why. Radiol Med 2022;127(3):228–37. doi: https://doi.org/10.1007/s11547-022-01450-3 [published Online First: 2022/01/19]